markets

MedApps is targeting market segments that need a more cost-effective solution, the ability to monitor a greater number of patients, or need to address changing regulatory policies.

re-hospitalization

With the passage of the Patient Protection and Affordable Care Act in March of 2010, the Center for Medicare and Medicaid Services (CMS) will implement a penalty policy in October 2012 for hospitals and providers with excess readmission rates. MedApps has the solutions in place to help providers address these needs in the rapidly changing healthcare landscape.



Accountable Care

CMS is moving towards deploying larger sums of money with organizations to take care of a patient (or group), instead of paying out every time a provider bills (Fee for Service). Major providers are joining Accountable Care Organizations (ACO’s) – a network of care providers that have shared responsibility of care for their patients and look to achieve better results while utilizing fewer resources. MedApps has the solutions to help maximize these resources.

Home Healthcare

A majority of Telehealth 1.0 systems today are deployed with Home Healthcare Agencies throughout the US. Many of these agencies are contracted by payers to provide services for patients based on negotiated, capitated costs.  This requires that the agency absorb any expenses for patient care above the negotiated cost paid by the payer. MedApps has products and services to help these organizations reduce costs with better healthcare delivery and improve profitability.

Clinical Trials

With over 2 million new people taking anticoagulation medication, like Coumadin / Warfin, every year to prevent blood clots, stroke, and heart attacks – the need for careful monitoring of these users has never been greater. Correct medication dosing is important to assure the best outcomes for these patients. MedApps has an innovative new way for patients to be monitored from home, instead of traveling to the doctor’s office or clinic for a blood draw, or sending a resource to the patient’s home.

OEM Integration

Manufacturers of health related OEM devices will find great value in partnering with MedApps to bring their data to the cloud. As the healthcare industry shifts to electronic medical records – and wireless healthcare and remote monitoring explodes – it will be increasingly vital that developers of medical sensors / monitors are able to efficiently port the data obtained by their products to wherever caregivers need it. The MedApps CloudCare platform can provides that capability quickly and cost-effectively.



Coagulation Monitoring

With over 2 million new people taking anticoagulation medication, like Coumadin / Warfin, every year to prevent blood clots, stroke, and heart attacks – the need for careful monitoring of these users has never been greater. Correct medication dosing is important to assure the best outcomes for these patients. MedApps has an innovative new way for patients to be monitored from home, instead of traveling to the doctor’s office or clinic for a blood draw, or sending a resource to the patient’s home.

pAYORS

Early adopters of remote patient monitoring technology have been organizations that are financially responsible for a patient population across the continuum of care. These organizations that have self-funded home telehealth initiatives reap strong financial benefit by utilizing this type of healthcare delivery and indicate that a meaningful return on investment exists for both the payor and provider. MedApps can bring enhanced value to these organizations’ telehealth programs by implementing more cost-effective solutions that are more efficient for the enterprise to deploy and maintain.

Providers

This has restricted deployment to a limited subset of patients – typically the most ill of patients – to justify the cost and effort of implementation.  This results in healthcare being delivered in a “reactive” versus “proactive” mode and the benefits of remote patient monitoring has been limited to a small fraction of the potential population that could actually benefit from such technology.  MedApps can help providers reach more patients more efficiently to improve patient compliance and outcomes while delivering meaningful reduction in related costs.



CONSUMERS

Lack of meaningful reimbursement for remote patient monitoring has made marketing direct to consumers challenging.  However many customers have learned the value of MedApps’ product offerings through practical use.  People who use HealthPAL to manage their own conditions not only enjoy the convenience of not logging health measurements manually, they’ve experienced a better quality of life by staying better connected with their care provider.  Other users receive peace of mind by being connected with loved ones whose health they care about – whether it’s a child at school or an older family member in another state.



Quality You Expect.